Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

0.3800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.3400 (53)
Ask (Size) 0.5300 (10)
Prev. Close 0.3800
Today's Range 0.3800 - 0.3800
52wk Range 0.3000 - 3.130
Shares Outstanding 25,088,414
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 38 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
  
Via Benzinga

Performance

YTD
-81.64%
-81.64%
1 Month
-8.03%
-8.03%
3 Month
-37.75%
-37.75%
6 Month
-76.97%
-76.97%
1 Year
-85.38%
-85.38%

More News

Read More
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Galmed Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Galmed's Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal Model
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Galmed Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Recap: Galmed Pharmaceuticals Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Raymond James Maintains Outperform Rating for Galmed Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022
Via Benzinga
Galmed Pharmaceuticals's Earnings Outlook
Via Benzinga
Galmed Pharmaceuticals Q4 2021 Earnings Conference Call On May 2, 2022 At 08:30 AM ET
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Earnings Scheduled For May 2, 2022
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
Via Benzinga
Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
Via Benzinga
Galmed's Anti-Inflammatory Compound Shows Encouraging Preclinical Action
Via Benzinga
61 Biggest Movers From Yesterday
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.